Ifosfamide studies for primary or recurrent pediatric malignant solid tumors and leukemia.
Ongoing studies using ifosfamide with mesna for primary or recurrent pediatric malignancies are reviewed. These studies include evaluations of ifosfamide given before conventional agents, in combination with other agents, with other effective agents and radiation therapy, and in alternative schedules.